{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T15:06:00Z","timestamp":1724943960467},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ghpjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.genhosppsych.2014.03.011","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T11:09:54Z","timestamp":1395572994000},"page":"451.e5-451.e6","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Priapism associated with iloperidone: a case report"],"prefix":"10.1016","volume":"36","author":[{"given":"Lisette A.","family":"Rodriguez-Cabezas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty Y.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurava","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0005","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1464-4096.2001.01510.x","article-title":"Low-flow priapism: risk factors for erectile dysfunction","volume":"89","author":"El-Bahnasawy","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/YIC.0b013e3282f1c1ef","article-title":"Priapism associated with atypical antipsychotic medications: a review","volume":"23","author":"Sood","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/JCP.0b013e3181c8273d","article-title":"Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity","volume":"30","author":"Andersohn","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0040","series-title":"Fanapt (iloperidone) package insert. Rockville, MD","article-title":"Vanda Pharmaceuticals I","year":"2013"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0045","first-page":"13","article-title":"Iloperidone (Fanapt) \u2014 another second-generation antipsychotic","volume":"52","year":"2010","journal-title":"Med Lett Drugs Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.genhosppsych.2014.03.011_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003088-199500291-00004","article-title":"Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6","volume":"29","author":"Ereshefsky","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0055","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/17425255.2010.531259","article-title":"Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion","volume":"6","author":"Citrome","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0060","series-title":"Clinical pharmacology [database online]","year":"2013"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3371\/CSRP.6.1.5","article-title":"Iloperidone for the treatment of schizophrenia: an updated clinical review","volume":"6","author":"Weiden","year":"2012","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0070","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/070674370404901223","article-title":"Priapism","volume":"49","author":"du Toit","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2014.03.011_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2045125312464104","article-title":"Priapism associated with risperidone: a case report, literature review and review of the South London and Maudsley hospital patients' database","volume":"3","author":"Paklet","year":"2013","journal-title":"Ther Adv Psychopharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834314000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834314000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T20:43:04Z","timestamp":1565296984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834314000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0163834314000747"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.03.011","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priapism associated with iloperidone: a case report","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}